Bristol Myers Squibb reports favorable data from a Phase 3 trial evaluating the dual immunotherapy combination of Opdivo (nivolumab) plus Yervoy (ipil...
FDA warns Mississauga, Canada-based Techlem Medical Corporation about Quality System violations in its manufacture of misbranded wheeled stretchers.
Arrow International recalls (Class 1) its Arrow FiberOptix Intra-Aortic Balloon Catheter Kit after receiving reports about infrequent device malfuncti...
Three stakeholders give technical suggestions to change an FDA draft guidance on data integrity for in vivo bioavailability and bioequivalence studies...
Federal Register notice: FDA issues an order debarring Michael Terry Little for five years from importing or offering for import any drug into the U.S...
Agios Pharmaceuticals plans to submit by the end of the year an NDA for mitapivat and its use on adults with transfusion-dependent alpha- or beta-thal...
FDA places a partial clinical hold on a Blueprint Medicines early-stage trial testing its experimental cancer drug because of safety concerns.
Takeda says it is moving its narcolepsy Type 1 drug TAK-861 to a Phase 3 trial after reporting positive results from a Phase 2b trial.
